SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: Gary Korn who wrote (654)11/10/1999 4:49:00 PM
From: George the Greek  Read Replies (1) | Respond to of 10345
 
re: Zonegran, et al
by: dgher 11/10/1999 3:52 pm EST
Msg: 3760 of 3760
I listened to a Merrill Lynch sponsored ... yesterday
...In response to accounting issues, they (as peviously disclosed) plan to buy back Axogen and Neurolab this quarter.

Gary,
Can you interpret for me (statement about Axogen, Neurolab)?
Thanks.

George
P.S.: interesting to dream about an acquisition valuation of $57/share.



To: Gary Korn who wrote (654)11/10/1999 7:33:00 PM
From: blankmind  Read Replies (1) | Respond to of 10345
 
for those of us trying to lower out price by purchasing through naked puts, your article makes one think of closing out the naked put, and just purchasing the stock and wish i had seen this before the close today....


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News